MG53 constitutes a primary determinant of cardiac ischemic preconditioning

scientific article published on 01 June 2010

MG53 constitutes a primary determinant of cardiac ischemic preconditioning is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/CIRCULATIONAHA.110.954628
P698PubMed publication ID20516375

P50authorHiroshi TakeshimaQ64106482
Ruisheng SongQ83341909
P2093author name stringLi Jin
Yan Zhang
Yi Zhang
Xianhua Wang
Wei Peng
Jianjie Ma
Miyuki Nishi
Chun-Mei Cao
Geng Li
Rui-Ping Xiao
Noah Weisleder
Christopher Ferrante
Fengxiang Lv
Jiaojiao Guo
Moonsun Hwang
P433issue23
P304page(s)2565-2574
P577publication date2010-06-01
P1433published inCirculationQ578091
P1476titleMG53 constitutes a primary determinant of cardiac ischemic preconditioning
P478volume121

Reverse relations

cites work (P2860)
Q90179654A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release
Q35984468Amelioration of ischemia-reperfusion-induced muscle injury by the recombinant human MG53 protein
Q54463273Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro.
Q46615618CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.
Q34357881Calcium-sensing receptor: a sensor and mediator of ischemic preconditioning in the heart
Q35881667Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury
Q36687738Cardioprotective Role of Caveolae in Ischemia-Reperfusion Injury.
Q35286413Caveolins in cardioprotection - translatability and mechanisms
Q35277772Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoprotein
Q41791619Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
Q47448021Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases
Q43178154Diabetic cardiomyopathy: catabolism driving metabolism
Q38833439Dual function of MG53 in membrane repair and insulin signaling
Q36085192Dysferlin and animal models for dysferlinopathy
Q37648514Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury
Q90424209EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition
Q35581794Effect of metabolic syndrome on mitsugumin 53 expression and function
Q33639038Effect of recombinant human MG53 protein on tourniquet-induced ischemia-reperfusion injury in rat muscle
Q35146479Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells
Q91762736Enhancing membrane repair increases regeneration in a sciatic injury model
Q30512833Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters.
Q33878140Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice
Q54456708Fenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.
Q35017049Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection
Q89349261Inhaled TRIM72 Protein Protects Ventilation Injury to the Lung through Injury-guided Cell Repair
Q34558225Ischemic preconditioning inhibits mitochondrial permeability transition pore opening through the PTEN/PDE4 signaling pathway
Q28237074KCNE2 modulates cardiac L-type Ca(2+) channel
Q36812645Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
Q64241892MG 53 Protein Protects Aortic Valve Interstitial Cells From Membrane Injury and Fibrocalcific Remodeling
Q38617502MG53 is dispensable for T-tubule maturation but critical for maintaining T-tubule integrity following cardiac stress.
Q35037331MG53 participates in ischaemic postconditioning through the RISK signalling pathway
Q97587404MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling
Q35915152MG53-mediated cell membrane repair protects against acute kidney injury
Q58575722Melatonin attenuates chronic pain related myocardial ischemic susceptibility through inhibiting RIP3-MLKL/CaMKII dependent necroptosis
Q36146335Membrane Repair: Mechanisms and Pathophysiology.
Q30828501Mitsugumin 53 regulates extracellular Ca(2+) entry and intracellular Ca(2+) release via Orai1 and RyR1 in skeletal muscle
Q43110566Mitsugumin-53: potential biomarker and therapeutic for myocardial ischemic injury?
Q33675082Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits
Q27312202Modulation of wound healing and scar formation by MG53 protein-mediated cell membrane repair.
Q42209023Muscle membrane repair and inflammatory attack in dysferlinopathy.
Q46747841Non-canonical roles for caveolin in regulation of membrane repair and mitochondria: implications for stress adaptation with age.
Q30513782Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.
Q34276258Novel therapeutic strategies for ischemic heart disease
Q36240722Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis
Q37130733Poloxamer 188 (p188) as a membrane resealing reagent in biomedical applications
Q34787002Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair
Q39156357Propofol inhibits expression of angiotensin II receptor type 2 in dorsal root ganglion neurons.
Q30545559Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy
Q35086766Redox-dependent oligomerization through a leucine zipper motif is essential for MG53-mediated cell membrane repair
Q89978268Remote Ischemic Preconditioning induces Cardioprotective Autophagy and Signals through the IL-6-Dependent JAK-STAT Pathway
Q64942829Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.
Q37637150S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death.
Q36813137S-nitrosylation of TRIM72 mends the broken heart: a molecular modifier-mediated cardioprotection
Q41450780SRSF1 promotes vascular smooth muscle cell proliferation through a Δ133p53/EGR1/KLF5 pathway.
Q38179749Signaling by S-nitrosylation in the heart
Q90662760Sustained elevation of MG53 in the bloodstream increases tissue regenerative capacity without compromising metabolic function
Q37698757TIR/BB-loop mimetic AS-1 attenuates cardiac ischemia/reperfusion injury via a caveolae and caveolin-3-dependent mechanism
Q34201280TRIM72 is required for effective repair of alveolar epithelial cell wounding.
Q35567034Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
Q91949826Targeting the PI3K/STAT3 axis modulates age-related differences in macrophage phenotype in rats with myocardial infarction
Q37294231The Akt1 isoform is an essential mediator of ischaemic preconditioning
Q33942287Treatment of acute lung injury by targeting MG53-mediated cell membrane repair
Q37639070Trimeric intracellular cation channels and sarcoplasmic/endoplasmic reticulum calcium homeostasis
Q35662277Zinc Binding to MG53 Protein Facilitates Repair of Injury to Cell Membranes
Q47237450Zinc in Wound Healing Modulation

Search more.